These findings were reinforced using isolated arteries from an established mouse model of dyslipidemia-induced endothelial dysfunction (Apolipoprotein E-deficient mouse; apoE–/–) (160), in which depletion of membrane cholesterol content rescued flow-induced vasodilation in a Kir2.1-dependent manner (159). This evidence concerns the gene APOE and metabolic syndrome.